Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-09

Clinical Trial Update: Efficacy and Safety Study of a Test Naproxen Sodium 220mg Tablet in Postoperative Dental Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of naproxen sodium 220 mg tablet for post-operative dental pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen sodium 220 mg tablet (naproxen sodium)

Snippet

Sponsor: Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | Conditions: Post-operative Dental Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-04-09